Catalyze B.V.
- Biotech or pharma, therapeutic R&D
- Financial, legal, consulting
- Medical device or technology
- Digital health
- Institute, hospital research
Catalyze supports life sciences companies and academics in acquiring (non-)dilutive funding in EU. We work on programs such as Horizon Europe, Eurostars, EIC, DoD, foundations (and more) and prepare investment propositions. With over €2B+ of non-dilutive funding acquired for our client portfolio, Catalyze is the market leader in acquiring non-dilutive financing for EU life science start-ups.



